Web Analytics

3 Latest Announced Rounds

  • $38,000,000
    Series C

    1 Investors

    Financial Services
    Aug 5th, 2025
  • $8,000,000
    Unknown
    Pharmaceutical Manufacturing
    Aug 5th, 2025
  • $2,600,000
    Pre-Seed

    2 Investors

    Software Development
    Aug 5th, 2025
$1,267.05M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Therini Bio, Inc.

start up
United States - South San Francisco, CA
  • 27/04/2023
  • Series A
  • $36,000,000

Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction. Our approach will be generally applicable across a range of inflammatory diseases including peripheral indications. The current therapeutic target is based on novel findings by the Akassoglou lab at Gladstone/UCSF that implicate fibrin as a key driver of neuroinflammation.


Related People

Michael QuigleyFounder

Michael Quigley United States - San Francisco Bay Area

N/A